TAKE SOLUTIONS LTD.

Take Solutions Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will continue until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window is closed for promoters, directors, key management personnel, designated employees, and their immediate relatives to prevent insider trading.

Take Solutions Ltd has resubmitted its Audited Financial Results for the year ended March 31, 2026, to comply with the prescribed format for the Statement on Impact of Audit Qualifications. The company clarified that there are no changes to the financial results previously approved by the Board. The resubmission addresses a qualified opinion from auditors A. Raghavendra Rao & Associates regarding the recoverability of income tax assets amounting to ₹875.80 Lakh, related to past assessment years and pending disputes. The auditors are unable to confirm the ultimate realizable value of these tax assets due to ongoing litigation. This qualification is a repeat from the year ended March 31, 2023. The auditors also highlighted the company's significant turnaround, with a profit of ₹271.91 Lakh for FY26 compared to a loss of ₹6,973.56 Lakh in the previous year, supported by business diversification and debt obligation clearance.

Take Solutions Ltd. announced the resignation of Mr. Ashok Ajay Kumar Bantia as Secretarial Auditor, effective May 29, 2026. Simultaneously, based on the Audit Committee's recommendation, M/s. Hemang Satra & Associates were appointed as the new Secretarial Auditor for a five-year term, commencing from Financial Year 2025-26 up to Financial Year 2029-30, subject to shareholder approval. The decisions were made during the Board of Directors meeting held on May 30, 2026.

Take Solutions Ltd reported strong financial performance for FY26, with consolidated total income rising to ₹6,087.26 Lakhs, a 495.68% year-on-year growth. The company's revenue from operations stood at ₹5,418.53 Lakhs, marking a new operational growth phase. Net profit for FY26 was ₹1,084.91 Lakhs, with an EPS of ₹0.74 per share. For Q4 FY26, consolidated total income surged to ₹5,937.02 Lakhs, a 3400% year-on-year increase. The company continues to focus on AI-driven healthcare solutions and digital wellness platforms, launching a ₹5 crore Innovation Fund.

TAKE Solutions Ltd reported strong financial results for FY26, with consolidated total income surging by 495.68% to ₹6,087.26 Lakhs. The company's net profit stood at ₹1,084.91 Lakhs, with an EPS of ₹0.74 per share. Revenue from operations reached ₹5,418.53 Lakhs, marking a new phase of operational growth. The company's Q4 FY26 consolidated total income increased by 3400% YoY to ₹5,937.02 Lakhs. TAKE Solutions is focusing on AI-driven healthcare solutions and launched a ₹5 crore Innovation Fund.

TAKE Solutions Ltd reported strong financial results for FY26, with consolidated total income increasing by 495.68% YoY to ₹6,087.26 Lakhs. The company's revenue from operations stood at ₹5,418.53 Lakhs, marking a new operational growth phase. Net profit for FY26 was ₹1,084.91 Lakhs, with an EPS of ₹0.74 per share. The company also reported a significant increase in Q4 FY26 consolidated total income, up 3400% YoY to ₹5,937.02 Lakhs. TAKE Solutions is focusing on AI-driven healthcare solutions and launched a ₹5 crore Innovation Fund.

Take Solutions Ltd has appointed Mr. Sunil Patra (DIN: 11728362) as Managing Director and Chief Financial Officer of the company, effective May 19, 2026. The appointment is subject to shareholder approval at the next general meeting or within three months. Mr. Patra has experience in customer service operations, business coordination, and handling operational and financial matters. He has also submitted a certificate of non-debarment.

Take Solutions Ltd has announced that a meeting of the Board of Directors is scheduled for May 20, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The trading window, which was closed from April 1, 2026, will reopen 48 hours after the declaration of the audited financial results.

Take Solutions Ltd's board approved changing the company's name to TAKE LIMITED, pending approval from the Ministry of Corporate Affairs and members. They also approved the appointment of A. Raghavendra Rao & Associates as statutory auditors, adopted a new Memorandum of Association, and altered the object clause to include healthcare technology and related sectors. A postal ballot will seek member approval, with e-voting from May 18 to June 16, 2026. Hemang Satra & Associates will act as scrutinizer for the ballot.

Take Solutions Limited announced its strategic entry into India's rapidly expanding longevity and anti-ageing market. The company plans to leverage its expertise in clinical research, life sciences, and regulatory processes to develop science-backed nutraceuticals, biohacking solutions, and technology-enabled preventive healthcare offerings. This initiative aligns with the company's strategy to expand in preventive and digital healthcare. The global longevity market is projected to reach USD 67.03 billion by 2035. In India, the anti-aging supplements market is expected to grow from USD 168.6 million in 2025 to USD 341.4 million by 2033, while the anti-aging services market is projected to reach USD 1,059.6 million by 2035. Take Solutions aims to build a diversified revenue mix across consumer products, services, and digital platforms.